Receptors for PTH and PTHrP: Their biological importance and functional properties

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Mannstadt, Michael ^a,b   Jüppner, Harald ^a   Gardella, Thomas J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Class II G protein coupled receptor; Constitutively active receptor; Parathyroid hormone; Parathyroid hormone related peptide; Peptide hormone family; Photochemical cross linking; Receptor binding; Receptor mutagenesis; Receptor mutations in human disease; Signal transduction; Structure activity relationship

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN;

CARTILAGE CELL; CELL GROWTH; CELL MATURATION; CHONDRODYSPLASIA; CROSS LINKING; GENE MUTATION; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPERCALCEMIA; KIDNEY; NONHUMAN; OSTEOPOROSIS; PHOTOAFFINITY LABELING; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PSEUDOHYPOPARATHYROIDISM; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 0032735547     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.5.f665     Document Type: Review

References (123)

1. Abou-Samra, A.-B., S. Uneno, H. Jüppner, H. Keutmann, J. T. Potts, Jr., G. V. Segre, and S. R. Nussbaum. Nonhomologous sequences of parathyroid hormone and the parathyroid hormone related peptide bind to a common receptor on ROS 17/2.8 cells. Endocrinology 125: 2215-2217, 1989.
2. Adams, A., A. Bisello, M. Chorev, M. Rosenblatt, and L. Suva. Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone. Mol. Endocrinol. 12: 1673-1683, 1998.
3. Amizuka, N., H. S. Lee, M. Y. Khan, A. Arazani, H. Warhawsky, G. N. Hendy, H. Ozawa, J. H. White, and D. Goltzman. Cell-specific expression of the parathyroid hormone (PTH)/PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promoters. Endocrinology 138: 469-481, 1997.
4. 15]-(1-34)). J. Biol. Chem. 273: 29572-29578, 1997.
5. Barden, J. A., and B. E. Kemp. Stabilized NMR structure of the hypercalcemia of malignancy peptide PTHrP[Ala-26](1-34)amide. Biochim. Biophys. Acta 1208: 256-262, 1994.
6. Behar, V., C. Nakamoto, Z. Greenberg, A. Bisello, L. J. Suva, M. Rosenblatt, and M. Chorev. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes. Endocrinology 137: 4217-4224, 1996.
7. Bergwitz, C., T. J. Gardella, M. R. Flannery, J. T. Potts, H. M. Kronenberg, S. R. Goldring, and H. Jüppner. Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. J. Biol. Chem. 271: 26469-26472, 1996.
8. Bergwitz, C., S. A. Jusseaume, M. D. Luck, H. Jüppner, and T. J. Gardella. Residues in the membrane-spanning and extracellular regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J. Biol. Chem. 272: 28861-28868, 1997.
9. Bettoun, J. D., M. Minagawa, G. N. Hendy, L. C. Alpert, C. G. Goodyer, D. Goltzman, and J. H. White. Developmental upregulation of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters. J. Clin. Invest. 102: 958-967, 1998.
10. Bettoun, J. D., M. Minagawa, M. Y. Kwan, H. S. Lee, T. Yasuda, G. N. Hendy, D. Goltzman, and J. H. White. Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 82: 1031-1040, 1997.
11. Bisello, A., A. E. Adams, D. F. Mierke, M. Pellegrini, M. Rosenblatt, L. J. Suva, and M. Chorev. Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J. Biol. Chem. 273: 22498-22505, 1998.
12. Blind, E., T. Bambino, Z. Huang, M. Bliziotes, and R. A. Nissenson. Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptor. J. Bone Miner. Res. 11: 578-586, 1996.
13. Blind, E., T. Bambino, and R. A. Nissenson. Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136: 4271-4277, 1995.
14. Blomstrand, S., I. Claësson, and J. Säve-Söderbergh. A case of lethal congenital dwarfism with accelerated skeletal maturation. Pediatr. Radiol. 15: 141-143, 1985.
15. Bringhurst, F. R. Calcium and phosphate distribution, turnover, and metabolic actions. In: Endocrinology, edited by L. J. DeGroot. Philadelphia, PA: Saunders, 1989, p. 805-843.
16. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
17. Caulfield, M. P., and M. Rosenblatt. Parathyroid hormone-receptor interactions. Trends Endocrinol. Metab. 2: 164-168, 1990.
18. Cheng, L., and B. Sacktor. Sodium gradient-dependent phosphate transport in renal brush border vesicles. J. Biol. Chem. 256: 1556-1564, 1981.
19. Clark, J. A., T. I. Bonner, A. S. Kim, and T. B. Usdin. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors. Mol. Endocrinol. 12: 193-206, 1998.
20. Cohen, F. E., G. J. Strewler, M. S. Bradley, M. Carlquist, M. Nilsson, M. Ericsson, T. L. Ciardelli, and R. A. Nissenson. Analogues of parathyroid hormone modified at positions 3 and 6: effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J. Biol. Chem. 266: 1997-2004, 1991.
21. Dong, M., Y. Wang, D. Pinon, E. Hadac, and L. Miller. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J. Biol. Chem. 274: 903-909, 1999.
22. Donnelly, D. The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett. 409: 431-436, 1997.
23. Drezner, M. K. Phosphorus homeostasis and related disorders. In: Principles in Bone Biology, edited by J. P. Bilezikian, L. G. Raisz, and G. A. Rodan. New York: Academic, 1996, p. 263-276.
24. Everhart-Caye, M., S. E. Inzucchi, J. Guinness-Henry, M. A. Mitnick, and A. F. Stewart. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH-(1-34) in humans. J. Clin. Endocrinol. Metab. 81: 199-208, 1996.
25. Farrens, D. L., C. Altenbach, K. Yang, W. L. Hubbell, and H. G. Khorana. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274: 768-770, 1996.
26. Fraher, L. J., A. B. Hodsman, K. Jonas, D. Saunders, C. I. Rose, J. E. Henderson, G. N. Hendy, and D. Goltzman. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J. Clin. Endocrinol. Metab. 75: 417-423, 1992.
27. Fraser, D. R., and E. Kodicek. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nature 241: 163-166, 1973.
28. Friedman, P. A., F. A. Gesek, P. Morley, J. F. Whitfield, and G. E. Willick. Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells. Endocrinology 140: 301-309, 1999.
29. Fukumoto, S., M. Suzawa, T. Kikuchi, T. Matsumoto, S. Kato, and T. Fujita. Cloning and characterization of kidney-specific promoter of human PTH/PTHrP receptor gene: absence of mutation in patients with pseudohypoparathyroidism type Ib. Mol. Cell. Endocrinol. 141: 41-47, 1998.
30. Fukumoto, S., M. Suzawa, Y. Takeuchi, K. Nakayama, Y. Kodama, E. Ogata, and T. Matsumoto. Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 81: 2554-2558, 1996.
31. Gagnon, L., H. Jouishomme, J. F. Whitfield, J. P. Durkin, S. MacLean, W. Neugebauer, G. Willick, R. H. Rixon, and B. Chakravarthy. Protein kinase C-activating domains of parathyroid hormone-related protein. J. Bone Miner. Res. 8: 497-503, 1993.
32. Garabedian, M., M. F. Holick, H. F. Deluca, and I. T. Boyle. Control of 25-hydrocholecalciferol metabolism by parathyroid glands. Proc. Natl. Acad. Sci. USA 69: 1673-1676, 1972.
33. 2]PTH-(1-34) binding and signaling in the transmembrane region of the parathyroid hormone receptor. Endocrinology 135: 1186-1194, 1994.
34. Gardella, T. J., M. D. Luck, M.-H. Fan, and C. W. Lee. Transmembrane residues of the parathyroid hormone (PTH)/ PTH-related peptide receptor that specifically affect binding and signaling by agonist ligands. J. Biol. Chem. 271: 12820-12825, 1996.
35. Gardella, T. J., M. D. Luck, G. S. Jensen, E. Schipani, J. T. Potts, Jr., and H. Jüppner. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors linked to Jansen's metaphyseal chondrodysplasia. Endocrinology 137: 3936-3941, 1996.
36. Gardella, T. J., M. D. Luck, G. S. Jensen, T. B. Usdin, and H. Jüppner. Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist. J. Biol. Chem. 271: 19888-19893, 1996.
37. Gardella, T. J., M. D. Luck, A. K. Wilson, H. T. Keutmann, S. R. Nussbaum, J. T. Potts, Jr., and H. M. Kronenberg. Parathyroid hormone (PTH)/PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand. J. Biol. Chem. 270: 6584-6588, 1995.
38. Goltzman, D., A. Peytremann, E. Callahan, G. W. Tregear, and J. T. Potts, Jr. Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues. J. Biol. Chem. 250: 3199-3203, 1975.
39. Guo, J., A. Iida-Klein, X. Huang, A. B. Abou-Samra, G. V. Segre, and F. R. Bringhurst. Parathyroid hormone (PTH)/ PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells. Endocrinology 136: 3884-3891, 1995.
40. Holick, M. F., S. Ray, T. C. Chen, X. Tian, and K. S. Persons. A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. Proc. Natl. Acad. Sci. USA 91: 8014-8016, 1994.
41. Holtmann, M., E. Hadac, and L. Miller. Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. J. Biol. Chem. 270: 14394-14398, 1995.
42. Holtmann, M. H., E. M. Hadac, C. D. Ulrich, and L. J. Miller. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor. J. Pharmacol. Exp. Ther. 279: 555-560, 1996.
43. Horiuchi, N., M. P. Caulfield, J. E. Fisher, M. E. Goldman, R. L. McKee, J. E. Reagan, J. J. Levy, R. F. Nutt, S. B. Rodan, T. L. Schofield, T. L. Clemens, and M. Rosenblatt. Similarity of synthetic peptide from human tumour to parathyroid hormone in vivo and in vitro. Science 238: 1566-1568, 1987.
44. Horiuchi, N., M. F. Holick, J. T. Potts, Jr., and M. Rosenblatt. A parathyroid hormone inhibitor in vivo: design and biologic evaluation of a hormone analog. Science 220: 1053-1055, 1983.
45. 2+ signal transduction pathways. J. Biol. Chem. 271: 33382-33389, 1996.
46. Iida-Klein, A., J. Guo, M. Takemura, M. T. Drake, J. T. Potts, Jr., A. Abou-Samra, F. R. Bringhurst, and G. V. Segre. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J. Biol. Chem. 272: 6882-6889, 1997.
47. Iida-Klein, A., J. Guo, L. Y. Xie, H. Jüppner, J. T. Potts, Jr., H. M. Kronenberg, F. R. Bringhurst, A. B. Abou-Samra, and G. V. Segre. Truncation of the carboxyl-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylate cyclase but not phospholipase C. J. Biol. Chem. 270: 8458-8465, 1995.
48. Inomata, N., M. Akiyama, N. Kubota, and H. Jüppner. Characterization of a novel PTH-receptor with specificity for the carboxyl-terminal region of PTH-(1-84). Endocrinology 136: 4732-4740, 1995.
49. Ji, T. H., M. Grossmann, and I. Ji. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273: 17299-17302, 1998.
50. Jobert, A. S., P. Zhang, A. Couvineau, J. Bonaventure, J. Roume, M. LeMerrer, and C. Silve. Absence of functional receptors parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J. Clin. Invest. 102: 34-40, 1998.
51. Jouishomme, H., J. F. Whitfield, B. Chakravarthy, J. P. Durkin, L. Gagnon, R. J. Isaacs, S. MacLean, W. Neugebauer, G. Willick, and R. H. Rixon. The protein kinase-C activation domain of the parathyroid hormone. Endocrinology 130: 53-59, 1992.
52. Jouishomme, H., J. F. Whitfield, L. Gagnon, S. Maclean, R. Isaacs, B. Chakravarthy, J. Durkin, W. Neugebauer, G. Willick, and R. H. Rixon. Further definition of the protein kinase C activation domain of the parathyroid hormone. J. Bone Miner. Res. 9: 943-949, 1994.
53. Joun, H., B. Lanske, M. Karperien, F. Qian, L. Defize, and A. Abou-Samra. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: a new PTH/PTHrP receptor splice variant that lacks the signal peptide. Endocrinology 138: 1742-1749, 1997.
54. Jüppner, H., E. Schipani, M. Bastepe, D. E. C. Cole, M. L. Lawson, M. Mannstadt, G. N. Hendy, H. Plotkin, H. Koshiyama, T. Koh, J. D. Crawford, B. R. Olsen, and M. Vikkula. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc. Natl. Acad. Sci. USA 95: 11798-11803, 1998.
55. Jüppner, H., E. Schipani, F. R. Bringhurst, I. McClure, H. T. Keutmann, J. T. Potts, Jr., H. M. Kronenberg, A. B. Abou-Samra, G. V. Segre, and T. J. Gardella. The extracellular, amino-terminal region of the parathyroid hormone (PTH)/ PTH-related peptide (PTHrP) receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology 134: 879-884, 1994.
56. Karaplis, A., B. He, M. Nguyen, I. Young, D. Semeraro, H. Ozawa, and N. Amizuka. Inactivating mutation in the human PTH receptor type 1 gene in blomstrand chondrodysplasia. Endocrinology 139: 5255-5258, 1998.
57. Karaplis, A. C., A. Luz, J. Glowacki, R. Bronson, V. Tybulewicz, H. M. Kronenberg, and R. C. Mulligan. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8: 277-289, 1994.
58. Karaplis, A. C., T. Yasuda, G. N. Hendy, D. Goltzman, and D. Banville. Gene encoding parathyroid hormone-like peptide: nucleotide sequence of the rat gene and comparison with the human homologue. Mol. Endocrinol. 4: 441-446, 1990.
59. Kemp, B. E., J. M. Mosely, C. P. Rodda, P. R. Ebeling, R. E. H. Wettenhall, D. Stapleton, H. Diefenbach-Jagger, F. Ure, V. P. Michelangali, H. A. Simmons, L. G. Raisz, and T. J. Martin. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238: 1568-1570, 1987.
60. Kolakowski, L. F. J. GCRDb: a G-protein-coupled receptor database. Receptors Channels 2: 1-7, 1994.
61. Kovacs, C. S., B. Lanske, J. L. Hunzelman, J. Guo, A. C. Karaplis, and H. M. Kronenberg. Parathyroid hormone-related peptide (PTHrP) regulates fetal placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc. Natl. Acad. Sci. USA 93: 15233-15238, 1996.
62. Kronenberg, H. M., F. R. Bringhurst, S. Nussbaum, H. Jüppner, A. B. Abou-Samra, G. V. Segre, and J. T. Potts, Jr. Parathyroid hormone: biosynthesis, secretion, chemistry, and action. In: Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone, edited by G. R. Mundy and T. J. Martin. Heidelberg: Springer-Verlag, 1993, p. 185-201.
63. Lanske, B., A. C. Karaplis, A. Luz, A. Vortkamp, A. Pirro, M. Karperien, L. H. K. Defize, C. Ho, R. C. Mulligan, A. B. Abou-Samra, H. Jüppner, G. V. Segre, and H. M. Kronenberg. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273: 663-666, 1996.
64. Lee, C., M. D. Luck, H. Jüppner, J. T. Potts, Jr., H. M. Kronenberg, and T. J. Gardella. Homolog-scanning mutagenesis of the parathyroid hormone (PTH) receptor reveals PTH-(1-34) binding determinants in the third extracellular loop. Mol. Endocrinol. 9: 1269-1278, 1995.
65. Lee, K., D. Brown, P. Urena, N. Ardaillou, R. Ardaillou, J. Deeds, and G. V. Segre. Localization of parathyroid hormone/ parathyroid hormone-related peptide receptor mRNA in kidney. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F186-F191, 1996.
66. Lee, K., J. D. Deeds, and G. V. Segre. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acid during fetal development of rats. Endocrinology 136: 453-463, 1995.
67. Lee, K., B. Lanske, A. C. Karaplis, J. D. Deeds, H. Kohno, R. A. Nissenson, H. M. Kronenberg, and G. V. Segre. Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137: 5109-5118, 1996.
68. Levine, M. A. Pseudohypoparathyroidism. In: Principles of Bone Biology, edited by J. P. Bilezikian, L. G. Raisz, and G. A. Rodan. New York: Academic, 1996, p. 853-876.
69. Malecz, N., T. Bambino, M. Bencsik, and R. Nissenson. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol. Endocrinol. 12: 1846-1856, 1998.
70. Malmström, K., and H. Murer. Parathyroid hormone regulates phosphate transport in OK cells via an irreversible inactivation of a membrane protein. FEBS Lett. 216: 257-260, 1987.
71. Mangin, M., A. C. Webb, B. E. Dreyer, J. T. Posillico, K. Ikeda, E. C. Weir, A. F. Stewart, N. H. Bander, L. Milstone, D. E. Barton, U. Francke, and A. E. Broadus. Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemic of malig-nancy. Proc. Natl. Acad. Sci. USA 85: 597-601, 1988.
72. Mannstadt, M., M. Luck, T. J. Gardella, and H. Jüppner. Evidence for a ligand interaction site at the amino-terminus of the PTH/PTHrP receptor from crosslinking and mutational studies. J. Biol. Chem. 273: 16890-16896, 1998.
73. Marx, U., S. Austermann, P. Bayer, K. Adermann, A. Ejchart, H. Sticht, S. Walters, F. Schmid, R. Jaenicke, W. Forssmann, and P. Rosch. Structure of human parathyroid hormone 1-37 in solution. J. Biol. Chem. 270: 15194-15202, 1995.
74. Massfelder, T., C. Saussine, U. Simeoni, B. Enanga, C. Judes, and J. J. Helwig. Evidence for adenylyl cyclase-dependent receptors for parathyroid hormone (PTH)-related protein in rabbit kidney glomeruli. Life Sci. 53: 875-878, 1993.
75. McCuaig, K. A., H. Lee, J. C. Clarke, H. Assar, J. Horsford, and J. H. White. Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters. Nucleic Acids Res. 23: 1948-1955, 1995.
76. Morel, F., M. Imbert-Teboul, and D. Charbardes. Distribution of hormone-dependent adenylate cyclase in the nephron and its physiological significance. Annu. Rev. Physiol. 43: 569-581, 1981.
77. Moseley, J. M., M. Kubota, H. Diefenbach-Jagger, R. E. H. Wettenhall, B. E. Kemp, L. J. Suva, C. P. Rodda, P. R. Ebeling, P. J. Hudson, J. D. Zajac, and J. T. Martin. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. USA 84: 5048-5052, 1987.
78. Murray, T., E. Gomez Rao, M. M. Wong, J. P. Waddell, R. McBroom, C. S. Tam, F. Rosen, and M. A. Levine. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J. Bone Miner. Res. 8: 83-91, 1993.
79. Nutley, M. T., S. A. Parimi, and S. Harvey. Sequence analysis of hypothalamic parathyroid hormone messenger ribonucleic acid. Endocrinology 136: 5600-5607, 1995.
80. Pellegrini, M., M. Royo, M. Rosenblatt, M. Chorev, and D. Mierke. Addressing the tertiary structure of human parathyroid hormone-(1-34). J. Biol. Chem. 273: 10420-10427, 1998.
81. i cotransporter. Proc. Natl. Acad. Sci. USA 95: 1909-1914, 1998.
82. Philbrick, W. M., E. C. Weir, A. C. Karaplis, B. E. Dreyer, and A. E. Broadus. Rescue of the PTHrP-null mouse reveals multiple developmental defects. J. Bone Miner. Res. 11, Suppl. 1: P268, 1996.
83. Pines, M., A. E. Adams, S. Stueckle, R. Bessalle, V. Rashti-Behar, M. Chorev, M. Rosenblatt, and L. J. Suva. Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a COOH-terminal human PTH peptide. Endocrinology 135: 1713-1716, 1994.
84. Potts, J. T., Jr., and H. Jüppner. Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism, and bone development: the proteins, their genes, and receptors. In: Metabolic Bone Disease, edited by L. V. Avioli and S. M. Krane. New York: Academic, 1997, p. 51-94.
85. Qian, F., A. Leung, and A. Abou-Samra. Agonist-dependent phosphorylation of the parathyroid hormone/parathyroid hormone-related peptide receptor. Biochemistry 37: 6240-6246, 1998.
86. Quinn, J. M., J. Elliott, M. T. Gillespie, and T. J. Martin. A combination of osteoclast differentiation factor and macrophagecolony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139: 4424-4427, 1998.
87. Schipani, E., K. Kruse, and H. Jüppner. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-100, 1995.
88. Schipani, E., C. Langman, J. Hunzelman, M. Le Merrer, K. Y. Loke, M. J. Dillon, C. Silve, and H. Jüppner. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodylsplasia. J. Clin. Endocrinol. Metab. In press.
89. Schipani, E., C. B. Langman, A. M. Parfitt, G. S. Jensen, S. Kikuchi, S. W. Kooh, W. G. Cole, and H. Jüppner. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N. Engl. J. Med. 335: 708-714, 1996.
90. Schipani, E., B. Lanske, J. Hunzelman, C. S. Kovacs, K. Lee, A. Pirro, H. M. Kronenberg, and H. Jüppner. Targeted expression of constitutively active PTH/PTHrP receptors delays endochondral bone formation and rescues PTHrP-less mice. Proc. Natl. Acad. Sci. USA 94: 13689-13694, 1997.
91. Schipani, E., L. S. Weinstein, C. Bergwitz, A. Iida-Klein, X. F. Kong, M. Stuhrmann, K. Kruse, M. P. Whyte, T. Murray, J. Schmidtke, C. van Dop, A. S. Brickman, J. D. Crawford, J. T. Potts, Jr., H. M. Kronenberg, A. B. Abou-Samra, G. V. Segre, and H. Jüppner. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J. Clin. Endocrinol. Metab. 80: 1611-1621, 1995.
92. Segre, G. V. Receptors for parathyroid hormone and parathyroid hormone-related protein. In: Principles in Bone Biology, edited by J. P. Bilezikian, L. G. Raisz, and G. A. Rodan. New York: Academic, 1996, p. 377-403.
93. Segre, G. V., and S. R. Goldring. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G protein-linked receptor family. Trends Endocrinol. Metab. 4: 309-314, 1993.
94. Silve, C., A. Santora, N. Breslau, A. Moses, and A. Spiegel. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 62: 640-644, 1986.
95. Silve, C., F. Suarez, A. El Hessni, A. Loiseau, A. M. Graulet, and J. Gueris. The resistance to parathyroid hormone of fibroblasts from some patients with type Ib pseudohypoparathyroidism is reversible with dexamethasone. J. Clin. Endocrinol. Metab. 71: 631-638, 1990.
96. Sraer, J., J. D. Sraer, D. Chansel, H. Jueppner, R. D. Hesch, and R. Ardaillou. Evidence for glomerular receptors for parathyroid hormone. Am. J. Physiol. 235 (Renal Fluid Electrolyte Physiol. 4): F96-F103, 1978.
97. Stewart, A. F., R. Horst, L. J. Deftos, E. C. Cadman, R. Lang, and A. E. Broadus. Biochemical evaluation of patients with cancer-associated hypercalcemia. Evidence for humoral and non-humoral groups. N. Engl. J. Med. 303: 1377-1381, 1980.
98. Strewler, G. J., P. H. Stern, J. W. Jacobs, J. Eveloff, R. F. Klein, S. C. Leung, M. Rosenblatt, and R. A. Nissenson. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 80: 1803-1807, 1987.
99. Stroop, S. D., R. E. Kuestner, T. F. Serwold, L. Chen, and E. E. Moore. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry 34: 1050-1057, 1995.
100. Suarez, F., J. J. Lebrun, D. Lecossier, B. Escoubet, C. Coureau, and C. Silve. Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 80: 965-970, 1995.
101. Suva, L. J., G. A. Winslow, R. E. Wettenhall, R. G. Hammonds, J. M. Moseley, H. Diefenbach-Jagger, C. P. Rodda, B. E. Kemp, H. Rodriguez, E. Y. Chen, P. J. Hudson, J. T. Martin, and W. I. Wood. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
102. Takasu, H., H. Baba, N. Inomata, Y. Uchiyama, N. Kubota, K. Kumaki, A. Matsumoto, K. Nakajima, T. Kimura, S. Sakakibara, T. Fujita, K. Chihara, and I. Nagai. The 69-84 amino acid region of the parathyroid hormone molecule is essential for the interaction of the hormone with the binding sites with carboxyl-terminal specificity. Endocrinology 137: 5537-5543, 1996.
103. Takasu, H., and F. R. Bringhurst. Type-1 parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH-(1-34). Endocrinology 139: 4293-4299, 1998.
104. Takasu, H., J. Guo, and F. Bringhurst. Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J. Bone Miner. Res. 14: 11-20, 1999.
105. Tawfeek, H. A., J. Che, F. Qian, and A. Abou-Samra. Internalization of a green fluorescent protein-tagged rat PTH/ PTHrP receptor (Abstract). Bone 23, Suppl. 1: S164, 1998.
106. Tian, J., M. Smorgorzewski, L. Kedes, and S. G. Massry. Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. J. Am. Soc. Nephrol. 13: 210-213, 1993.
107. Tregear, G. W., J. Van Rietschoten, E. Greene, H. T. Keutmann, H. D. Niall, B. Reit, J. A. Parsons, and J. T. Potts, Jr. Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology 93: 1349-1353, 1973.
108. Turner, P. R., T. Bambino, and R. A. Nissenson. Mutations of neighboring polar residues on the second transmembrane helix disrupt signaling by the parathyroid hormone receptor. Mol. Endocrinol. 10: 132-139, 1996.
109. Turner, P. R., T. Bambino, and R. A. Nissenson. A putative selectivity filter in the G-protein-coupled receptors for parathyroid hormone and secretin. J. Biol. Chem. 271: 9205-9208, 1996.
110. Turner, P. R., S. Mefford, T. Bambino, and R. A. Nissenson. Transmembrane residues together with the amino-terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide. J. Biol. Chem. 273: 3830-3837, 1998.
111. Urena, P., X. F. Kong, A. B. Abou-Samra, H. Jüppner, H. M. Kronenberg, J. T. Potts, Jr., and G. V. Segre. Parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA are widely distributed in rat tissues. Endocrinology 133: 617-623, 1993.
112. Usdin, T. B., T. I. Bonner, G. Harta, and E. Mezey. Distribution of PTH-2 receptor messenger RNA in rat. Endocrinology 137: 4285-4297, 1996.
113. Usdin, T. B., C. Gruber, and T. I. Bonner. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J. Biol. Chem. 270: 15455-15458, 1995.
114. van Dop, C. Pseudohypoparathyroidism: clinical and molecular aspects. Semin. Nephrol. 9: 168-178, 1989.
115. Vasavada, R. C., C. Cavaliere, A. J. D'Ercole, P. Dann, W. J. Burtis, A. L. Madlener, K. Zawalich, W. M. Philbrick, and A. F. Stewart. Overexpression of parathyroid hormone-related protein in the pancreatic islet of transgenic mice causes islet hyperplasia, hyperinsulinemia and hypoglycemia. J. Biol. Chem. 271: 1200-1208, 1996.
116. Vortkamp, A., K. Lee, B. Lanske, G. V. Segre, H. M. Kronenberg, and C. J. Tabin. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273: 613-622, 1996.
117. s deficiency. In: G Proteins, Receptors, and Disease, edited by A. M. Spiegel. Totowa, NJ: Humana, 1998, p. 23-56.
118. Weir, E. C., W. M. Philbrick, M. Amling, L. A. Neff, R. Baron, and A. E. Broadus. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes skeletal dysplasia and delayed endochondral bone formation. Proc. Natl. Acad. Sci. USA 93: 10240-10245, 1996.
119. Wu, T. L., R. C. Vasavada, K. Yang, T. Massfelder, M. Ganz, S. K. Abbas, A. D. Care, and A. F. Stewart. Structural and physiological characterization of the mid-region secretory species of parathyroid hormone-related protein. J. Biol. Chem. 271: 24371-24381, 1996.
120. Wysolmerski, J. J., A. E. Broadus, J. Zhou, E. Fuchs, L. M. Milstone, and W. M. Philbrick. Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc. Natl. Acad. Sci. USA 91: 1133-1137, 1994.
121. Wysolmerski, J. J., J. F. McCaughern-Carucci, A. G. Daifotis, A. E. Broadus, and W. M. Philbrick. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 121: 3539-3547, 1996.
122. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. I. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda. Osteoclast differentia-tion factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597-3602, 1998.
123. Zhang, P., A. S. Jobert, A. Couvineau, and C. Silve. A homozygous inactivating mutation in the parathyroid hormone/ parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J. Clin. Endocrinol. Metab. 83: 3373-3376, 1998.